[1]王建民,高鹏,刘杰慧,等.miR-373在视网膜母细胞瘤Y79细胞中的表达及其抑制侵袭及迁移能力的实验研究[J].眼科新进展,2018,38(10):947-950.[doi:10.13389/j.cnki.rao.2018.0224]
 WANG Jian-Min,GAO Peng,LIU Jie-Hui,et al.Expression of miR-373 in retinoblastoma Y79 cells and its inhibitory effect on cell invasion and migration[J].Recent Advances in Ophthalmology,2018,38(10):947-950.[doi:10.13389/j.cnki.rao.2018.0224]
点击复制

miR-373在视网膜母细胞瘤Y79细胞中的表达及其抑制侵袭及迁移能力的实验研究/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年10期
页码:
947-950
栏目:
实验研究
出版日期:
2018-10-05

文章信息/Info

Title:
Expression of miR-373 in retinoblastoma Y79 cells and its inhibitory effect on cell invasion and migration
作者:
王建民高鹏刘杰慧张加宾
271100 山东省莱芜市,泰山医学院附属莱芜医院眼科(王建民,高鹏,张加宾);250013 山东省济南市,山东大学附属济南市中心医院眼科(刘杰慧)
Author(s):
WANG Jian-MinGAO PengLIU Jie-HuiZHANG Jia-Bin
Department of Ophthalmology,Laiwu Hospital Affiliated to Taishan Medical University(WANG Jian-Min,GAO Peng,ZHANG Jia-Bin),Laiwu 271100,Shandong Province,China;Department of Ophthalmology,Jinan Central Hospital Affiliated to Shandong University(LIU Jie-Hui),Jinan 250013,Shandong Province,China
关键词:
视网膜母细胞瘤miR-373侵袭迁移上皮间质转化
Keywords:
retinoblastomamiR-373invasionmigrationepithelial-mesenchymal transition
分类号:
R774
DOI:
10.13389/j.cnki.rao.2018.0224
文献标志码:
A
摘要:
目的 观察miR-373在视网膜母细胞瘤(retinoblastoma,RB)细胞中的表达及其对RB Y79细胞侵袭及迁移能力的影响和相关机制。方法 采用实时荧光定量PCR(qRT-PCR)检测miR-373在RB细胞系RB Y79、SO-RB50和人正常视网膜血管内皮细胞系ACBRI-181中的表达水平,并应用脂质体转染法将miR-373 抑制物(miR-373抑制物组)和阴性对照(NC组)分别转染至Y79细胞,Transwell实验检测Y79细胞侵袭和迁移能力的变化,Western blot检测Y79细胞中上皮间质转化(epithelial-mesenchymal transition,EMT)相关标志物E-Cadherin、Vimentin和N-Cadherin蛋白的表达变化。结果 qRT-PCR 结果显示,RB细胞系Y79、SO-RB50中miR-373的相对表达量分别为6.21±0.34、5.40±0.38,明显高于人正常视网膜血管内皮细胞系ACBRI-181中miR-373的相对表达量(1.02±0.04)(均为P<0.05)。Transwell实验显示,miR-373抑制物组迁移细胞数(74±13)个,明显低于NC组(180±17)个(P<0.05),miR-373抑制物组侵袭细胞数(51±9)个明显低于NC组(113±14)个(P<0.05)。Western blot结果显示,miR-373抑制物组E-Cadherin蛋白的表达(0.40±0.08)明显高于NC组(0.20±0.06)(P<0.05),Vimentin蛋白的表达(0.17±0.06)也明显低于NC组(0.51±0.10)(P<0.05),N-Cadherin蛋白的表达(0.12±0.06)也明显低于NC组(0.33±0.08)(P<0.05)。结论 miR-373在RB细胞中表达异常增高,降低miR-373的表达能够通过调控EMT抑制RB Y79细胞的侵袭和迁移能力,为RB的靶向治疗提供了新的潜在靶点。
Abstract:
Objective To investigate the expression of miR-373 in retinoblastoma (RB) cells,and its effect on the invasion and migration of RB Y79 cell as well as the relevant mechanisms.Methods Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-373 in RB cell lines,RB Y79 and SO-RB50,as well as human normal retinal vascular endothelial cell line,ACBRI-181.miR-373 inhibitor (miR-373 inhibitor group) and inhibitor-NC (NC group) were separately transfected into Y79 cells using liposome transfection.Afterwards,Transwell assay was utilized to determine the changes of invasion and migration of Y79 cells.Western blot was used to detect the expressions of epithelial-mesenchymal transition (EMT) markers,including E-Cadherin,Vimentin and N-Cadherin,in Y79 cells.Results The results of qRT-PCR showed that the relative expression of miR-373 in the RB cell line,Y79 and SO-RB50,was 6.21±0.34 and 5.40±0.38,respectively,which was significantly higher than that in the normal retinal vascular endothelial cell line ACBRI-181(1.02±0.04)(both P<0.05).The Transwell test showed that the number of migratory cells in the miR-373 inhibitor group (74±13) was significantly lower than that of the NC group (180±17) (P<0.05),and the number of invasive cells in the miR-373 inhibitor group (51±9) was significantly lower than that of the NC group (113±14) (P<0.05).The results of Western blot showed that the expression of E-Cadherin protein in the miR-373 inhibitor group (0.40±0.08) was significantly higher than that in the NC group (0.20±0.06) (P<0.05),and the expression of Vimentin protein (0.17±0.06) was also significantly lower than that of the NC group (0.51±0.10) (P<0.05),and the expression of N-Cadherin protein (0.12±0.06) was also significantly lower than that of NC group (0.33±0.08) (P<0.05).Conclusion The expression of miR-373 abnormally increases in RB cells.Down-regulation of miR-373 expression can inhibit the invasion and migration abilities of RB Y79 cells by the regulation of EMT,which provids a novel potential target for targeted therapy of RB.

参考文献/References:

[1] ABRAMSON D H.Retinoblastoma in the 20th century:past success and future challenges the Weisenfeld lecture[J].Invest Ophthalmol Vis Sci,2005,46(8):2683-2691.
[2] KIVEL T.The epidemiological challenge of the most frequent eye cancer:retinoblastoma,an issue of birth and death[J].Br J Ophthalmol,2009,93(9):1129-1131.
[3] GRUBER A R,MARTIN G,MLLER P,SCHMIDT A,GRUBER A J,GUMIENNY R,et al.Global 3’UTR shortening has a limited effect on protein abundance in proliferating T cells[J].Nat Commun,2014,5:5465.
[4] ZHOU P,XU W,PENG X,LUO Z,XING Q,CHEN X,et al.Large-scale screens of miRNA-mRNA interactions unveiled that the 3’UTR of a gene is targeted by multiple miRNAs[J].PLoS One,2013,8(7):e68204.
[5] ZHANG X,LI X,TAN Z,LIU X,YANG C,DING X,et al.MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer,contributing to tumorigenesis[J].Oncol Lett,2013,6(5):1427-1434.
[6] GUANCIAL E A,BELLMUNT J,YEH S,ROSENBERG J E,BERMAN D M.The evolving understanding of microRNA in bladder cancer[J].Urol Oncol,2014,32(1):e31-40.
[7] CHEN Y J,LUO J,YANG G Y,YANG K,WEN S Q,ZOU S Q.Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma[J].World J Gastroenterol,2012,18(29):3849-3861.
[8] YANG Y,MEI Q.miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression[J].Mol Vis,2015,21:1307-1317.
[9] ZHAO J J,YANG J,LIN J,YAO N,ZHU Y,ZHENG J,et al.Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis[J].Childs Nerv Syst,2009,25(1):13-20.
[10] ZHAO Y,ZHANG S,ZHANG Y.MicroRNA-320 inhibits cell proliferation,migration and invasion in retinoblastoma by targeting specificity protein 1[J].Mol Med Rep,2017,16(2):2191-2198.
[11] GUI F,HONG Z,YOU Z,WU H,ZHANG Y.MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway[J].Cell Biol Int,2016,40(12):1294-1302.
[12] SUN Z,ZHANG A,JIANG T,DU Z,CHE C,WANG F.MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19[J].Int J Clin Exp Pathol,2015,8(11):14521-14527.
[13] NIKAKI A,PIPERI C,PAPAVASSILIOU A G.Role of microRNAs in gliomagenesis:targeting miRNAs in glioblastoma multiforme therapy[J].Exp Opin Invest Drugs,2012,21(10):1475-1488.
[14] LIU P,WILSON M J.miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1,and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells[J].J Cell Physiol,2012,227(2):867-876.
[15] BING Z,MASTER S R,TOBIAS J W,BALDWIN D A,XU X W,TOMASZEWSKI J E.MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue[J].Virchows Arch,2012,461(6):663-668.
[16] TANAKA T,ARAI M,WU S,KANDA T,MIYAUCHI H,IMAZEKI F.Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer[J].Oncol Rep,2011,26(5):1329-1335.
[17] WEI F,WANG Q,SU Q,HUANG H,LUAN J,XU X,et al.miR-373 inhibits glioma cell U251 migration and invasion by down-regulating CD44 and TGFBR2[J].Cell Mol Neurobiol,2016,36(8):1389-1397.
[18] SEOL H S,AKIYAMA Y,SHIMADA S,LEE H J,KIM T I,CHUN S M,et al.Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes[J].Cancer Lett,2014,353(2):232-241.
[19] WEI F,CAO C,XU X,WANG J.Diverse functions of miR-373 in cancer[J].J Transl Med,2015,13:162.
[20] KATSUNO Y,LAMOUILLE S,DERYNCK R.TGF-β signaling and epithelial-mesenchymal transition in cancer progression[J].Curr Opin Oncol,2013,25(1):76-84.
[21] VOULGARI A,PINTZAS A.Epithelial-mesenchymal transition in cancer metastasis:mechanisms,markers and strategies to overcome drug resistance in the clinic[J].Biochim Biophys Acta,2009,1796(2):75-90.
[22] CHEN D,DANG B L,HUANG J Z,CHEN M,WU D,XU M L,et al.MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer[J].Oncotarget,2015,6(32):32701-32712.
[23] WENG J,ZHANG H,WANG C,LIANG J,CHEN G,LI W,et al.miR-373-3p targets DKK1 to promote emt-induced metastasis via the wnt/β-catenin pathway in tongue squamous cell carcinoma[J].Biomed Res Int,2017,2017:6010926.
[24] WANG L,QU J,ZHOU L,LIAO F,WANG J.MicroRNA-373 inhibits cell proliferation and invasion via targeting BRF2 in human non-small cell lung cancer A549 cell line[J].Biomed Res Int,2017,2017:6010926.
[25] NAKATA K,OHUCHIDA K,MIZUMOTO K,AISHIMA S,ODA Y,NAGAI E,et al.Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion[J].Ann Surg Oncol,2014,21(Suppl 4):S564-574.

相似文献/References:

[1]刘瑾 朱豫.视网膜母细胞瘤的治疗进展[J].眼科新进展,2013,33(1):000.
[2]常海敏 杨磊 千新来.Calphostin C对人视网膜母细胞瘤细胞增殖的抑制作用[J].眼科新进展,2013,33(9):000.
[3]崔平 南娜 康洁 李军会 申景然.白藜芦醇对人视网膜母细胞瘤细胞侵袭能力的影响及机制研究[J].眼科新进展,2012,32(1):000.
[4]宋念艺 陈绪涛 张娴.B超、CT及MRI检查在视网膜母细胞瘤诊断中的价值[J].眼科新进展,2012,32(10):000.
[5]张千帆 刘瑞敏 穆红梅 郭洋 申飞 刘莹.白藜芦醇对视网膜母细胞瘤Y79细胞增殖的影响及其机制[J].眼科新进展,2012,32(11):000.
[6]兰兰 惠延年 曾光伟.微小RNA与磷酸化胞外信号调节激酶在视网膜母细胞瘤中的表达及其相关性分析[J].眼科新进展,2013,33(6):000.
[7]覃冬菊,唐罗生,游庆华,等.HSP27、增殖细胞核抗原在视网膜母细胞瘤中的表达[J].眼科新进展,2010,30(5):000.
[8]蒋永强 吴晓梅 连金贤.视网膜母细胞瘤术后23 a未复发1例[J].眼科新进展,2009,29(1):000.
[9]陈雪 李海平 张培 曹安民. 小胶质细胞在视网膜母细胞瘤中的活化及分布研究[J].眼科新进展,2014,34(1):029.
[10]孙燕 张煦 王登廷 祝杰 郑吉琦. Livin、PTEN及MMP-9在视网膜母细胞瘤中的表达及相关性研究[J].眼科新进展,2014,34(2):135.

更新日期/Last Update: 2018-09-28